USUma Shankar Singh

Uma Shankar Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Uma Shankar Singh has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the paradigm of miRNA and cardiac troponin I expression in prolonged post-mortem interval

    by Paurabhi Singh, Wahid Ali, Sangram Sandhu, Mohd Wamique, Rashmi Kushwaha, Anoop K. Verma, Raja Rupani, Sangeeta Kumari, Uma Shankar Singh

    Background: Accurate post-mortem interval (PMI) determination remains crucial in forensic investigations. Building on our previous findings of miRNA-378, miRNA-206, and miRNA-195 as potential PMI biomarkers, this study evaluates their efficacy in burn and electrocution cases. We incorporate cardiac troponin I (cTnI) to enhance estimation precision. This multi-biomarker approach aims to elucidate the combined potential of miRNA and protein-based indicators for PMI determinations across diverse causes of mortality, addressing the need for more robust estimation methods. These biomarkers were studied in human cardiac tissues of burn and electrocution cases which was maintained at room temperature. Enzyme-linked immunosorbent assay (ELISA) and Real-time, polymerase chain reaction (RT-PCR) was used for cTnI and miRNA analysis, respectively. Result: In electrocution cases, a marked decrease in miRNA and cardiac troponin I (cTnI) expression correlates with increasing post-mortem interval (PMI). Specifically, miRNA-195 exhibited a 4.13-fold reduction from 3.1805 ± 1.873 at 12 h to -0.769 ± 2.111 at 196 h, with significant changes noted between 24 and 48 h (p < 0.05). miRNA-206 displayed a 2.2-fold decline, with variability observed particularly between 12 and 72 h (p < 0.05). ​cTnI revealed a substantial decrease, reinforcing its utility as an early PMI marker for electrocution fatalities.​ In contrast, burn cases showed an even sharper decline in miRNA-195 (6.84-fold), indicating a higher sensitivity to tissue degradation, while cTnI exhibited a more stable decrease. This comparative analysis illuminates distinct degradation patterns among biomarkers, enhancing their efficacy in PMI identification. Conclusion: We combined miRNA expression levels and cTnI concentrations to improve the accuracy of PMI estimation. Thus, relevance of time-dependent variations in miRNAs and cTnI, is investigated and highlighted the approach for optimal design of biomarkers and analytical techniques for PMI estimation.


  • Co-occurrence of hydatid cyst liver with acute myeloid leukaemia: A rare case report

    by Anurag Singh, Anuragani Verma, Rashmi Kushwaha, Uma Shankar Singh, Shailendra Prasad Verma


  • Open Access

    Hyperlipidemia and Platelet Parameters: Two Sides of the Same Coin

    by Anurag Singh, Anupam Singh, Rashmi Kushwaha, Geeta Yadav, Tanya Tripathi, S C. Chaudhary, Shailendra P. Verma, Uma S. Singh

    Introduction: Hyperlipidemia is a disorder in which lipid and cholesterol levels in the blood are elevated. Diabetes, coronary heart disease, obesity, and hypertension are commonly linked to hyperlipidemia. Despite this, hyperlipidemia is a widely neglected illness, owing to its asymptomatic nature, ignorance of aberrant lipid profiles on screening, and economic issues in poor countries such as India. Platelets have been shown to have a role in the thrombus consequences of atheromatous damage in hyperlipidemic individuals by initiating and propagating atherosclerotic plaques. Platelets with bigger diameters are thought to be more metabolically, enzymatically, and functionally agile than platelets with lower sizes. In steady-state operation, these bigger platelets release more thromboxane B2 than regular platelets. Platelets with bigger sizes are more hemostatically active and hence have a higher chance of forming a thrombus and thromboembolism. The aim of this study was to compare the values of key platelet parameters and platelet function in hyperlipidemic patients with normal age and sex-matched controls. Material and methods: A total of 100 individuals were included in this study, with 68 cases of hyperlipidemia and 32 controls having normal lipid profiles. Platelet volume indices (PVI) such as platelet count (PC), mean platelet volume (MPV), platelet distribution width (PDW), platelet large cell ratio (P-LCR), plateletcrit (PCT), and platelet function (platelet aggregation with adenosine diphosphate, ADP) were compared between hyperlipidemia patients and age sex-matched controls with normal lipid profiles. Results: The cases had a statistically significant higher mean MPV (10.55 ± 1.81), PDW (14.93 ± 2.82), and P-LCR (30.97 ± 11.74) compared to mean MPV (9.35 ± 1.85), PDW (13.10 ± 2.60), and P-LCR (25.13 ± 12.23) of controls (p-value < 0.05). No significant difference was observed between the study group and control group with respect to mean PC and PCT (p-value > 0.05). In this study, there was a statistically significant increase noted in platelet aggregation percentage in hyperlipidemic patients than in the control group (42.03 ± 25.28 vs 31.25 ± 15.11) (p-value < 0.05). Conclusion: To conclude, platelet parameters are a significant, easy, and cost-effective method for predicting future acute episodes in hyperlipidemic patients that should be utilized more widely. To avoid vascular events, these individuals may require higher antiplatelet dosages and more rigorous hyperlipidemia therapy.


  • Open Access

    Hematological Changes in the Second Wave of SARS-CoV-2 in North India

    by Akanksha Singh, Shailendra P. Verma, Rashmi Kushwaha, Wahid Ali, Himanshu D. Reddy, Uma S. Singh

    COVID-19 is a rapidly spreading pandemic caused by SARS-CoV-2. India experienced a second wave peak in mid of April 2021, and it emerged as a medical crisis. This study was taken up to show if the hematological and peripheral blood changes can be used as a readily available tool to demarcate the patients needing ICU care so that the ICU can be utilized more prudently. One hundred reverse transcription-polymerase chain reaction (RT-PCR) confirmed cases of COVID-19, 50 each from ICU and non-ICU wards, were included in this observational study. At the time of admission blood sample was collected for evaluation of hematological parameters. We noted that 74% of patients admitted in ICU were males and 28% were more than 60 years of age. In ICU patients, the absolute neutrophil count (ANC) was significantly raised when compared to non-ICU cases (p=0.023). The nadir absolute lymphocyte count (ALC) was 0.11x109/L in ICU patients and 0.95x109/L in non-ICU patients. There was a significant increase in neutrophil-lymphocyte ratio (NLR; p<0.001) in ICU patients with a proposed cut-off value of 7.73. Platelet-lymphocyte ratio (PLR) was also raised in ICU patients; however, this increase was not significant (p= 0.623). The proposed cut-off value of PLR is 126.73. A significant reduction in a lymphocyte-monocyte ratio (LMR) was observed in ICU patients when compared to non-ICU cases (p<0.001). Thrombocytopenia was more commonly seen in ICU patients; however, this was not statistically significant. Viral-induced cytopathic effects like plasmacytoid lymphocytes with cytoplasmic granules, the presence of toxic changes in neutrophils, and large-sized platelets were commonly observed in ICU patients. Our results suggest that hematological parameters like ANC, absolute lymphocyte count (ALC), platelet count, NLR, PLR, and peripheral smear changes are simple assessment factors that can serve as indicators for the severity of COVID-19 and will demarcate the patients who need ICU-care. This will help in the judicious use of ICU facilities for patients who are actually in need.


  • Open Access

    Circulating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome

    by Sandeep Kumar, Wahid Ali, Sridhar Mishra, Akshyaya Pradhan, Rishi Sethi, Rashmi Kushwaha, Uma Shankar Singh, Marco Alfonso Perrone

    Background: Cardiac troponin is the best marker to diagnose acute coronary syndrome (ACS). However, early diagnosis using markers for plaque instability may be of significance. Soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) plays an important role in the pathogenesis of atherosclerosis plaque rupture and may be a potential biomarker of coronary artery disease (CAD), including ACS. The current study aims to evaluate sLOX-1 levels in the sera of patients with ACS as an independent marker of CAD with other established diagnostic markers and assess its level before and after percutaneous intervention (PCI) in predicting the risk of future recurrence of ACS. Methods: Peripheral blood was obtained from a total of 160 patients, including patients who underwent coronary angiography (n = 18, group I), patients of stable CAD who underwent percutaneous intervention (n = 50, group II), patients of the acute coronary syndrome (n = 64, group III), and healthy controls (n = 28, group IV). A serum sLOX-1 concentration was measured by the enzyme-linked immunosorbent assay (ELISA). Results: The results obtained showed a statistically significant raised level of sLOX-1 in pre/post PCI patients of stable CAD/ACS with male preponderance. The area under the curve for sLOX-1 was 0.925 for cases that are discriminated from controls with sensitivity and specificity of 87.88 and 100%, respectively. SLOX-1 showed 100% sensitivity and specificity in the discrimination of the stable CAD that underwent PCI vs. control with an AUC of 1.00. The recurrence of coronary artery disease was observed in 9 out of 132 (6.8%) cases. The post-interventional sLOX-1 level was significantly different and higher in recurrent cases (p = 0.027) of ACS/CAD. Conclusions: sLOX-1 was a useful biomarker of stable CAD/ACS and has a potential in the risk prediction of a future recurrence of coronary artery disease.


  • Intentional and non-intentional burn related deaths: A comparative study of socio-demographic profile

    by Sachil Kumar, Uma Shankar Singh, Anoop K. Verma, Wahid Ali, Akhilesh Krishna